American Association for the Advancement of Science, Science Translational Medicine, 383(9), 2017
DOI: 10.1126/scitranslmed.aai7866
Full text: Unavailable
Poly(GP) proteins are a promising pharmacodynamic marker for developing and testing therapeutics for treating C9ORF72 -associated amyotrophic lateral sclerosis.